Cytosorbents Aktie (A12GDU

Aktuelle Nachrichten zu Cytosorbents

Weitere Nachrichten

Das berichten andere über Cytosorbents

CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor

By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORTNew Findings Presented at European Society of Cardiology (ESC) Congress 2026On September 2, 2026, the CytoSorbents...

CTSO: CytoSorbents Future Value Drivers Support Price Target of $4.00

By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORT2nd Quarter 2026 Financial ResultsOn August 6, 2026, CytoSorbents (NASDAQ: CTSO) released 2nd quarter financial...

OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA

NASDAQ: CTSOGreg Young: Hello and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, were very pleased you have...

CTSO: CytoSorbents Reports 1st Quarter Financial and Operating Results

By Tom Kerr, CFANASDAQ: CTSOREAD THE FULL CTSO RESEARCH REPORT1st Quarter 2026 Financial ResultsOn May 13, 2026, CytoSorbents (NASDAQ: CTSO) announced 1st quarter 2026 financial...